Rituximab therapy for primary glomerulonephritis: Report on two cases

about

Managing refractory cryoglobulinemic vasculitis: challenges and solutions Lupus-like Immune Complex-mediated Glomerulonephritis in Patients with Hepatitis C Virus Infection Treated with Oral, Interferon-free, Direct-acting Antiviral Therapy.

P2860

Q33673888-E8024AD7-D547-4105-93D6-CAD4FCE65E25 Q40404776-524019E3-0164-4762-AAE8-6DB4D2C4CAE6

P2860

Rituximab therapy for primary glomerulonephritis: Report on two cases

Item

http://www.wikidata.org/entity/Q41036642

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Rituximab therapy for primary glomerulonephritis: Report on two cases

@en

type

Item

label

Rituximab therapy for primary glomerulonephritis: Report on two cases

@en

prefLabel

Rituximab therapy for primary glomerulonephritis: Report on two cases

@en

P1476

Rituximab therapy for primary glomerulonephritis: Report on two cases

@en

P2093

Donata Cresseri

http://www.w3.org/2001/XMLSchema#string

Fabrizio Fabrizi

http://www.w3.org/2001/XMLSchema#string

Giovanni B Fogazzi

http://www.w3.org/2001/XMLSchema#string

Patrizia Passerini

http://www.w3.org/2001/XMLSchema#string

Paul Martin

http://www.w3.org/2001/XMLSchema#string

Piergiorgio Messa

http://www.w3.org/2001/XMLSchema#string

P2860

Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis

Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab).

Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment.

Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry.

Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey.

Rituximab therapy in idiopathic membranous nephropathy: a 2-year study.

A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis.

Rituximab treatment for membranous nephropathy: a French clinical and serological retrospective study of 28 patients.

Remission of refractory hepatitis C-negative cryoglobulinaemic vasculitis after rituximab and infliximab.

Rituximab in idiopathic membranous nephropathy.

P304

736-742

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.12998/WJCC.V3.I8.736

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gabriella Moroni

P577

2015-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26301235

http://www.w3.org/2001/XMLSchema#string

P921

glomerulonephritis

P932

4539414

http://www.w3.org/2001/XMLSchema#string

Rituximab therapy for primary glomerulonephritis: Report on two cases

about

P2860

P2860

Rituximab therapy for primary glomerulonephritis: Report on two cases

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932